Benzinga's Top Upgrades

Analysts at Canaccord Genuity upgraded T Mobile U.S.

from “hold” to “buy.” The target price for T Mobile U.S. has been raised from $25 to $33. T Mobile's shares closed at $28.12 yesterday. Analysts at Sterne Agee upgraded Cardinal Health

from “neutral” to “buy.” The target price for Cardinal Health has been raised from $59 to $73. Cardinal Health's shares closed at $60.56 yesterday. Deutsche Bank upgraded Encana

from “sell” to “hold.” The target price for Encana has been raised from $17 to $22. Encana's shares closed at $18.34 yesterday. Analysts at Piper Jaffray upgraded Endo Health Solutions

from “underweight” to “neutral.” The target price for Endo Health Solutions has been raised from $26 to $58. Endo Health's shares closed at $56.22 yesterday.